ARTICLE | Cover Story
New axis in hypertension
May 7, 2009 7:00 AM UTC
U.S. and European researchers have found that deleting the prostaglandin
F receptor can lower both blood pressure and atherosclerotic plaque formation in mice.1 Now that the receptor has been shown to be involved in the renin-angiotensin system, it offers a new way to attack a pathway that has already yielded multiple marketed drugs...